Literature DB >> 9111266

Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey.

H Demiroğlu1, I Barişta, S Dündar.   

Abstract

BACKGROUND: Behcet's disease (BD) shows great regional differences in clinical manifestations and prognosis, including eye involvement. Thus, it is hard to predict in which patient the eyes will be involved and what the outcome will be. In this study we assessed various risk factors for eye involvement and attempted to predict the visual outcome in our patient population in Turkey.
METHODS: Data from a total of 224 patients with BD, diagnosed between 1982 and 1996, were analyzed retrospectively. A detailed physical examination and ophthalmologic work up were performed on each patient. Factors that might contribute to eye involvement were investigated, after which prognostic factors for vision were evaluated.
RESULTS: Eighty-eight patients had eye involvement during a median follow-up of 32 months. The risk of involvement was highest within the first year of diagnosis. Young age was the most significant factor for eye involvement (P < 0.0001), but vascular thrombosis, central nervous system (CNS) involvement, and male gender were other risk factors (P < 0.001; P < 0.01; and P < 0.05, respectively). The most important determinant for the prognosis of vision was CNS involvement (P < 0.0001). Vascular thrombosis and an age of < or = 32 were other risk factors for visual impairment (P < 0.001 and P < 0.05, respectively). The risk of eye involvement and prognosis for vision were similar with different treatment regimens (P > 0.05).
CONCLUSION: It is suggested that the first 2 years after diagnosis is the most critical period for eye involvement, and conventional forms of therapy generally are unsuccessful in preventing such involvement. It seems reasonable to treat patients who are at increased risk for eye involvement more aggressively, especially within the first 2 years of disease onset.

Entities:  

Mesh:

Year:  1997        PMID: 9111266     DOI: 10.1016/s0161-6420(97)30249-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Response to allegations and some considerations on interferon treatment in Behçet's disease.

Authors:  Haluk Demiroglu
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Late-onset Behçet's disease: demographic, clinical, and ocular features.

Authors:  Gulten Sungur; Dicle Hazirolan; Emre Hekimoglu; Remzi Kasim; Sunay Duman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-07       Impact factor: 3.117

3.  Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.

Authors:  Moncef Khairallah; Sonia Attia; Salim Ben Yahia; Salah Jenzeri; Rim Ghrissi; Bechir Jelliti; Sonia Zaouali; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2008-03-26       Impact factor: 2.031

4.  Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease.

Authors:  Abdullah Kursat Cingu; Fatih Mehmet Turkcu; Serdar Aktas; Alparslan Sahin; Orhan Ayyildiz
Journal:  Int Ophthalmol       Date:  2020-07-29       Impact factor: 2.031

5.  Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease.

Authors:  Toshikatsu Kaburaki; Fumiyuki Araki; Mitsuko Takamoto; Kimiko Okinaga; Atsushi Yoshida; Jiro Numaga; Yujiro Fujino; Hidetoshi Kawashima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-08       Impact factor: 3.117

6.  Cranial hypertension as first manifestation of Behçet's disease: a case report.

Authors:  F J Ascaso; A Rodriguez; J A Cristóbal
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

Review 7.  Mucocutaneous lesions of Behcet's disease.

Authors:  Erkan Alpsoy; Christos Constantin Zouboulis; George Edward Ehrlich
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

8.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

9.  Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.

Authors:  R Oktay Kaçmaz; John H Kempen; Craig Newcomb; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; C Stephen Foster
Journal:  Am J Ophthalmol       Date:  2008-08-16       Impact factor: 5.258

10.  Clinical features of Behcet's disease in Mongolia: a multicenter study.

Authors:  Javzandulam Balt; Baasankhuu Jamyanjav; Sarantuya Jav; Zulgerel Dandii; Chimedlkhamsuren Ganbold; Yukihiro Horie; Anton Lennikov; Osamu Uehara; Shigeaki Ohno; Nobuyoshi Kitaichi
Journal:  Clin Rheumatol       Date:  2020-03-10       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.